Citadel Advisors - ALLENA PHARMACEUTICALS INC ownership

ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 49 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALLENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$9,000
-47.1%
37,613
+26.1%
0.00%
Q4 2021$17,000
-59.5%
29,825
-36.5%
0.00%
Q3 2021$42,000
-32.3%
46,975
-1.4%
0.00%
Q2 2021$62,000
+138.5%
47,630
+192.8%
0.00%
Q2 2020$26,000
+23.8%
16,268
-24.0%
0.00%
Q1 2020$21,000
-44.7%
21,402
+53.5%
0.00%
Q4 2019$38,000
-36.7%
13,947
+27.1%
0.00%
Q4 2018$60,000
-48.3%
10,970
+1.8%
0.00%
Q3 2018$116,000
-6.5%
10,776
-4.3%
0.00%
Q1 2018$124,00011,2650.00%
Other shareholders
ALLENA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TRV GP II, LLC 2,790,964$2,518,00011.16%
AIGH Capital Management LLC 4,000,000$3,608,0000.76%
Worth Venture Partners, LLC 980,200$884,0000.40%
Altium Capital Management LP 1,067,886$963,0000.25%
FRAZIER MANAGEMENT LLC 3,330,373$3,005,0000.24%
Golden Green, Inc. 33,000$30,0000.02%
LEVEL FOUR FINANCIAL, LLC 40,000$36,0000.02%
GSA CAPITAL PARTNERS LLP 152,731$138,0000.01%
PFM Health Sciences, LP 284,285$256,0000.01%
XTX Topco Ltd 21,443$19,0000.01%
View complete list of ALLENA PHARMACEUTICALS INC shareholders